Financial News
Geron Corp (NQ: GERN )
1.820
USD
+0.030
(+1.68%)
Streaming Delayed Price
Updated: 12:16 PM EST, Mar 1, 2021
Add to My Watchlist
Stories about Geron Corp
The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines
October 01, 2019
From Benzinga
From Benzinga
5 Stocks To Watch For October 1, 2019
October 01, 2019
From Benzinga
4 Stocks Moving In Monday's After-Hours Session
September 30, 2019
From Benzinga
2 Biotech Stocks I Wouldn't Touch With a Broom
September 21, 2019
From Motley Fool
24 Healthcare Stocks Moving In Friday's Pre-Market Session
September 13, 2019
From Benzinga
Benzinga's Top Upgrades, Downgrades For September 3, 2019
September 03, 2019
From Benzinga
Tags
Stocks
From Market News Video
33 Healthcare Stocks Moving In Monday's Pre-Market Session
August 19, 2019
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 15, 2019
August 15, 2019
From Benzinga
26 Healthcare Stocks Moving In Thursday's Pre-Market Session
August 15, 2019
From Benzinga
From Motley Fool
What You'll Want to Know About Geron's Q2 Results
August 02, 2019
From Motley Fool
40 Healthcare Stocks Moving In Thursday's After-Market Session
August 02, 2019
From Benzinga
The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings
August 01, 2019
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
Did Geron's Big Announcement Just Go Unnoticed?
May 16, 2019
From Motley Fool
3 Cancer Treatment Stocks to Buy in April
April 20, 2019
From Motley Fool
From Benzinga
Benzinga's Top Upgrades, Downgrades For April 9, 2019
April 09, 2019
From Benzinga
3 Penny Stocks That Could Make You Rich -- or Regretful
March 14, 2019
From Motley Fool
3 Small-Cap Stocks With Big-Cap Potential
March 11, 2019
From Motley Fool
From Motley Fool
Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO
March 06, 2019
From Benzinga
Why Geron Skyrocketed 27% in February
March 05, 2019
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.